Ignite Creation Date:
2024-05-05 @ 5:02 PM
Last Modification Date:
2024-10-26 @ 9:27 AM
Study NCT ID:
NCT00376285
Status:
WITHDRAWN
Last Update Posted:
2015-04-22
First Post:
2006-09-13
Brief Title:
Effects of Fenofibrate on the Safety Toleration and Efficacy Biomarkers of CP-742033
Sponsor:
Pfizer
Organization:
Pfizer
Study Overview
Official Title:
A Phase 1 Randomized Investigator and Subject Blind Sponsor Open Study to Determine the Effects of Fenofibrate on the Safety Toleration and Efficacy Biomarkers of CP-742033 When Co-Administered in Otherwise Healthy Obese Adult Subjects
Status:
WITHDRAWN
Status Verified Date:
2015-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine whether fenofibrate effects the toleration safety or efficacy biomarkers of CP-742033 a drug being developed for the treatment of obesity
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None